Cellebrite (CLBT) chair Adam Clammer reports direct and indirect shareholdings
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Cellebrite DI Ltd. director Adam Clammer filed an initial ownership report showing his holdings of ordinary shares. He holds 71,396 shares directly, including 10,601 time-based RSUs that vest on September 17, 2026. Indirectly, he reports 13,861,007 shares held by TWC Tech Holdings II, LLC and 375,000 shares each held by a Long Term Trust and a Joint Revocable Trust, with 1,500,000 shares subject to transfer restrictions tied to performance-based vesting conditions. Clammer states he may be deemed to share beneficial ownership of certain securities but disclaims beneficial ownership beyond his pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
4 transactions reported
Mixed
4 txns
Insider
CLAMMER ADAM
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Ordinary Shares — 71,396 shares (Direct);
Ordinary Shares — 13,861,007 shares (Indirect, By TWC Tech Holdings II, LLC)
Footnotes (1)
- Includes 10,601 time-based restricted stock units ("RSUs") granted under the Cellebrite DI Ltd. (the "Issuer") 2021 Share Incentive Plan which vest on September 17, 2026. Includes 1,500,000 ordinary shares of the Issuer subject to transfer restrictions pending the satisfaction of certain performance-based vesting conditions. As one of the managing members of the ultimate controlling entity of TWC Tech Holdings II, LLC, Mr. Clammer may be deemed to have shared beneficial ownership of the securities held directly by TWC Tech Holdings II, LLC. Mr. Clammer disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, Mr. Clammer states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.
FAQ
What does Adam Clammer’s Form 3 filing for Cellebrite (CLBT) show?
The Form 3 shows Adam Clammer’s initial ownership in Cellebrite ordinary shares. It details direct holdings, indirect stakes through entities and trusts, and restricted and performance-based shares, providing a baseline view of his reported equity position as he serves as Chair of the Board.
Does Adam Clammer fully acknowledge beneficial ownership of all reported Cellebrite (CLBT) securities?
He expressly disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest. The filing states that including these securities should not be seen as an admission of full beneficial ownership for Section 16 or any other purpose.